Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective.

Autor: Marazziti D; Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy., Weiss F; Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy., Gurrieri R; Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy., Russomanno G; Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy., Gambini M; Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy., Magnesa A; Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy., Coccoglioniti A; Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy., Perugi G; Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy.

Publikováno v: Expert review of neurotherapeutics [Expert Rev Neurother] 2024 Dec 23, pp. 1-14. Date of Electronic Publication: 2024 Dec 23.